The ambiguous "internal carotid artery"-Ultrasound diagnosis of congenital absence of the internal carotid artery: A case report and review of the literature.

RATIONALE: Congenital anatomical variation of internal carotid artery (ICA) rarely occurs, and congenital absence of the ICA is even rarer. Few reports are available on the diagnosis of congenital absence of the ICA by carotid doppler ultrasound (CDUS), and most cases have been identified by computed tomographic angiography (CTA) or digital subtraction angiography (DSA). PATIENT CONCERNS: A 61-year-old male was admitted to our hospital due to dizziness for more than half a month. He was hypertensive and had been drinking and smoking for many years. DIAGNOSES: The patient was diagnosed by carotid doppler ultrasound with congenital absence of the right ICA, confirmed by CTA and DSA. A nodular aneurysm in the anterior communicating artery was observed by CTA and DSA. INTERVENTIONS: After relevant preoperative examinations were performed, the patient underwent right craniotomy and clipping of the aneurysm under general anesthesia 8 days after admission. OUTCOMES: The patient recovered well after surgery and no relapses has been observed. LESSONS: Congenital absence of the ICA is rare and usually diagnosed by CTA or DSA in clinical practice. If radiologists do not have adequate knowledge about the associated ultrasonic characteristics, a missed diagnosis may occur. As a noninvasive and rapid screening tool for cervical vascular diseases, carotid doppler ultrasound offers a new approach for the diagnosis of congenital absence of the ICA.

Case report: Multiple epstein-barr virus-associated smooth muscle tumours in a child with IL-2-inducible T-cell kinase mutation of undetermined clinical significance.

Background: EBV-associated smooth muscle tumours (EBV-SMTs) are uncommon neoplasms associated with immunodeficiency. The pathogenesis of EBV-SMTs is poorly understood. IL-2-inducible T-cell kinase (ITK), a member of the Tec family of tyrosine kinases, is the predominant Tec kinase in T cells. Researchers have shown that ITK is involved in the pathogenesis of autoimmune diseases and carcinogenesis, and the loss of ITK function due to mutation in patients can lead to EBV-associated lymphoproliferation. Multiple Epstein-Barr virus-associated smooth muscle tumours with ITK mutation have rarely been reported. Case presentation: A 6-year-old female child was admitted to the hospital due to recurrent bilateral hip pain for more than one year. Tumours were found in the lung, near the intracranial cavernous sinus and in the lumbar spine and paraspinal soft tissues by CT and MRI. The patient underwent vertebral tumour biopsy, which suggested low-grade myogenic or inflammatory myofibroblastic tumours, so the patient was given three courses of chemotherapy without symptom relief or mass reduction. The patient underwent lumbar mass resection, the pathological results indicated EBV-SMT, and a novel germline homozygous deletion mutation in the ITK gene was detected. The deletion mutation in this gene has not yet been reported and the clinical significance of the pathogenicity of the variant is unknown. Intrabronchial mass resection was performed under fibre bronchoscopy, and the pathological results indicated EBV-SMT. No significant recurrence or progression was observed after more than 2 years of follow-up. Conclusions: We present a rare case of multiple EBV-SMTs combined with ITK gene mutation. Some of the tumours were removed, and some were treated conservatively. There was no significant recurrence or progression after more than two years of follow-up. The optimal treatment regimen still needs to be further explored, and the relationship between ITK gene mutation at this locus and immunodeficiency and EBV-SMT warrants further investigation.

The effectiveness of eight-years phosphorus reducing inputs on double cropping paddy: Insights into productivity and soil-plant phosphorus trade-off.

Abundant evidence has demonstrated the feasibility of reducing phosphorus (P) input to face diminishing phosphate rock resources and deteriorating environmental quality in double-cropping paddy. However, the sustainability of reduced P input in the context of maintaining productivity and P efficient utilization is not yet clear. Herein, an 8-year (2013-2021) field-based database was built to explore the effects of reduced P input on rice productivity and the soil-plant P trade-off in double-cropping paddy. In the early and late rice seasons, compared with conventional P fertilization (early rice, 90 kg hm-2; late rice, 60 kg hm-2), the average yield of reduced 10 % P treatment increased by 4.3 % and 2.1 %, respectively; reduced 10-30 % P treatments increased average P use efficiency by 17.1-18.4 % and 14.0-17.2 %, decreased average total P runoff loss by 14.9-33.2 % and 20.8-36.4 %, and decreased average total P leaching loss by 18.5-49.0 % and 24.0-46.1 %, respectively. Compared with conventional fertilization, reduced P fertilizer input by 10 % significantly increased the content of the soil labile-P fraction while reducing that of the soil stable-P fraction. Soil ligand-P and exchangeable-P content decreased with the gradient reduction of P fertilizer input (10-30 %). The main predictors of the change in rice yield and plant P uptake were soil ligand-P and exchangeable-P content, respectively. The dominant predictor of both the P runoff loss and the P activation coefficient was the inorganic P content extracted by NaHCO3. These findings suggest that reduced P input by 10 % could maintain rice productivity and P use efficiency in the double-cropping paddy, and the transformations between soil P components and increases in P bioavailability may be the key drivers maintaining rice productivity and P utilization under the context of reduced P loading.

Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy.

The gut microbiota is a large symbiotic community of anaerobic and facultative aerobic bacteria inhabiting the human intestinal tract, and its activities significantly affect human health. Increasing evidence has suggested that the gut microbiome plays an important role in tumor-related immune regulation. In the tumor microenvironment (TME), the gut microbiome and its metabolites affect the differentiation and function of immune cells regulating the immune evasion of tumors. The gut microbiome can indirectly influence individual responses to various classical tumor immunotherapies, including immune checkpoint inhibitor therapy and adoptive immunotherapy. Microbial regulation through antibiotics, prebiotics, and fecal microbiota transplantation (FMT) optimize the composition of the gut microbiome, improving the efficacy of immunotherapy and bringing a new perspective and hope for tumor treatment.

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1.

BACKGROUND: MiR-216b has been reported to be involved in the development of some cancers, however, the role of miR-216b in colorectal cancer (CRC) remains unclear. PURPOSE: This study aimed to investigate the mechanism underlying miR-216b-induced CRC development. METHODS: We detected the expression of miR-216b in 80 cases of CRC tissues and cell lines, and further analyzed the association between miR-216b and clinical pathological indicators as well as prognosis. In vitro, the miR-216b overexpression cell model was established for further functional assay. RESULTS: We demonstrated that miR-216b in CRC tissues and cell lines was markedly decreased compared with corresponding adjacent normal tissues and colonic mucosal epithelial cell line, and was obviously associated with the TNM stage, lymph node metastases, and poor overall survival as well as recurrence-free survival. Furthermore, we found that miR-216b inhibited cell proliferation, cell cycle, migration, and invasion by targeting 3'-UTR of SRPK1. Besides, SRPK1 over-expression reversed miR-216b-inhibited cell proliferation, migration and invasion, while SRPK1 inhibition aggravated these effects. CONCLUSIONS: We identified that miR-216b suppresses colorectal cancer proliferation, migration and invasion by targeting SRPK1, which shed light on how miR-216b functions in CRC pathogenesis.

miR-126 Functions as a Tumor Suppressor by Targeting SRPK1 in Human Gastric Cancer.

The expression of miR-126 and serine-arginine protein kinase 1 (SRPK1) are linked to tumor development; nevertheless, its role in the tumor growth and invasion of gastric cancer (GC) and the underlying mechanism have not been clarified. Here the expression and role of miR-126 and SRPK1 were investigated in GC tissues and cells by in vitro assay, and then targets of miR-126 were identified by dual-luciferase reporter assay. In this study, miR-126 expression was downregulated and associated with lymph node metastasis and poor prognosis as well as SRPK1 expression. In vitro assay revealed that miR-126 obviously inhibited the proliferative and invasive capabilities of GC cells. The dual-luciferase reporter assay showed that miR-126 targets the 3'-UTR of SRPK1 and downregulates its expression. SRPK1 overexpression promoted cell migration and invasion. In conclusion, the reduced expression of miR-126 is suggestive of the risk of GC recurrence and metastasis, and miR-126 functions as a tumor suppressor by targeting SRPK1 expression in the development of GC.

[Establishment of method and evaluated criteria for newborn hearing screening in the gross-roots hospital].

OBJECTIVE: To study a optimal method and pass criterion for newborn hearing screening. METHOD: Transient evoked otoacoustic emissions(TEOAE) was used for hearing screening in 1,277 (2,554 ears) newborns. The pass criterion was defined as signal-noise-ratio(SNR) > or = 3 dB in 3 of 4 frequency bands. RESULT: Pass rates were 89.37%. The best tested time at 2-4 days after birth. CONCLUSION: TEOAE may be an ideal method for newborn hearing screening, SNR > or = 3 dB for frequency bands was the appropriate pass criteria.